Skip to content

Clinical trial of comparison the effect of honey drop and ciprofloxacin drop in corneal ulcer

Clinical trial comparison the therapeutic effect of honey drop and ciprofloxacin drop in corneal ulcer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015020120892N1
Enrollment
50
Registered
2015-10-11
Start date
2014-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal ulcer. Corneal ulcer

Interventions

Intervention 1: Intervention group 1: the patients that recieve topical honey drop 7o %( manufactured by pharmacologic center of Shiraz university of medical sciences).In this group drop of honey Ever
Treatment - Drugs
Intervention group 1: the patients that recieve topical honey drop 7o %( manufactured by pharmacologic center of Shiraz university of medical sciences).In this group drop of honey Every6 hours will be
Intervention group 2: The patient that receive Ciprofloxacin 0.3 (Sina darou company, Teh-IR, with IRC1228036651). In this group drop of Ciprofloxacin will be applied every 6 hours.all of the patie

Sponsors

Vice chancellor for research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:All patients that enrolled in this study are from patients that are reffered to eye emergency due to metalic foreign body; with corneal ulcer less than 2 mm; that are not in center of cornea without anterior chamber reaction. Exclusion criteria:corneral ulcers that located in center of cornea;or non metalic; or larger than 2 mm; or in the presence if anterior chamber reaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Size of ulcer.inflammation.epithelial healing. Timepoint: 1st,3rd,7th and 10th. Method of measurement: Slit Lamp and questionaeer.

Secondary

MeasureTime frame
Allergy to Honey. Timepoint: The Patient is Observed and Also alarm signs are taken to them. Method of measurement: With Clinical Exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Mahmood Nejabat

Shiraz University of Medical Sciences

Nejabatm@sums.ac.ir+98 71 3230 5410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 19, 2026